Most Viewed Articles on GWDN Last Week: Aug 6, 2012

Aug 06, 2012 | staff reporter

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

1) 23andMe Submits Documents for 510(k) Clearance from FDA
2) Earnings Season Sees Investors Sour on 'Omics Tools, MDx Firms
3) Sequencing Study IDs Ion Pump Gene in Rare Neurological Condition
4) White House Bioethics Commission Unveils Draft of Genomic Privacy Policies
5) GE Healthcare, NetBio Partner on DNA Products for Forensics Space

Breaking News

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.

Most Viewed Articles on GWDN Last Week: Aug 6, 2012

FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants

Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool

Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery

LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit

Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO

Twist Bioscience, DeepCDR Collaborate on Antibody Library Design

Booster for At-Risk

Preprints OK to Mention Again

Hundreds of Millions More to Share

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

Hexagon Bio Raises $61M in Private Financing Round

New PacBio Library Prep Method Helps Cover 'Death Valley' Between Short and Long Reads
Premium

Roche Nabs CE Mark for Three Cobas Respiratory Test Panels

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes
Premium

Aviv Scientific Closes $40M Series B Financing Round

Most Viewed Articles on GWDN Last Week: Aug 6, 2012

New PacBio Library Prep Method Helps Cover 'Death Valley' Between Short and Long Reads Premium

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes Premium

New PacBio Library Prep Method Helps Cover 'Death Valley' Between Short and Long Reads
Premium

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes
Premium